Fabrizio Loiacono Selected Research

Fabrizio Loiacono Research Topics

6	Neoplasms (Cancer) 01/2023 - 05/2010
3	Type 2 Diabetes Mellitus (MODY) 01/2023 - 09/2021
2	Leukemia 01/2022 - 08/2020
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2017 - 05/2014
2	Lymphoma (Lymphomas) 05/2014 - 05/2010
1	Hypoglycemia (Reactive Hypoglycemia) 01/2022
1	Hematologic Neoplasms (Hematological Malignancy) 01/2022
1	Ischemia 01/2022
1	Carcinoma (Carcinomatosis) 10/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2018
1	Lymphoid Leukemia 04/2015
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 05/2010
1	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 06/2007
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 04/2006

3	Insulin (Novolin)FDA Link 01/2023 - 09/2021
2	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2022
2	LigandsIBA 01/2023 - 05/2014
2	Signaling Lymphocytic Activation Molecule Associated ProteinIBA 01/2017 - 05/2014
1	spirooxindoleIBA 01/2023
1	TrehaloseIBA 01/2023
1	Trinitrotoluene (TNT)IBA 01/2022
1	Therapeutic UsesIBA 01/2022
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022
1	Oxygen (Dioxygen)IBA 01/2022
1	Arginine (L-Arginine)FDA Link 10/2021
1	CyclodextrinsIBA 10/2021
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 10/2021
1	PolymersIBA 10/2021
1	IntegrinsIBA 10/2021
1	ErbB Receptors (EGF Receptor)IBA 01/2018
1	CytokinesIBA 01/2017
1	Zoledronic Acid (Zometa)FDA Link 04/2015
1	AntibodiesIBA 05/2010
1	InterleukinsIBA 05/2010
1	interleukin-21 (interleukin 21)IBA 05/2010
1	Interleukin-2 (IL2)IBA 05/2010
1	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 06/2007
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 06/2007
1	DNA (Deoxyribonucleic Acid)IBA 04/2006

2	Hematopoietic Stem Cell Transplantation 08/2020 - 01/2016
1	Immunotherapy 01/2022
1	Drug Therapy (Chemotherapy) 10/2021
1	Transplantation 04/2015